For all the moves the Orioles have made this offseason, their rotation — perhaps their biggest downfall in 2025 — has a lot ...

Fear of asking questions is something many people experience, whether in classrooms, meetings, or social settings. Here’s how ...

As school leaders raise concerns about student cellphone use in schools, policymakers can look to domestic and international ...

Books & the Arts / Toni Morrison’s debut novel might be her most misunderstood. Namwali Serpell This essay is adapted from On ...

Cancer’s great chronicler and adversary, Siddhartha Mukherjee, tells survivor Chris Power why it will always be part of who we are. The first ...

Stranger Things has become a Netflix phenomenon by combining 1980s nostalgia, Dungeons & Dragons, the sci-fi and horror geekdoms, and Winona Ryder. We’ve watched a group of childhood friends fight ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

Tesla delivered a Q4 double-beat, with strong sequential gross margin expansion, despite a 16% year-over-year decline in EV deliveries. TSLA's gross margin rose to 20.1%, driven by cost efficiencies ...

Learn how to manage fatigue and maintain independence when you have metastatic breast cancer (MBC), with strategies like ...

Duolingo is undervalued by over 50%, with a DCF-derived fair value of ~$220/share and strong free cash flow. Find out why DUOL stock is a strong buy.

Feb. 4, 2026, 4:30 p.m. ET President and Chief Executive Officer — Stephen LaNeve Chief Financial Officer — Ali Pervaiz Senior Director, Investor Relations — Stephen Monroe Need a quote from a Motley ...

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?